Know Labs Inc
AMEX:KNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (29.9), the stock would be worth $-34.85 (4 407% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.7 | $0.81 |
0%
|
| Industry Average | 29.9 | $-34.85 |
-4 407%
|
| Country Average | 21.9 | $-25.48 |
-3 250%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
K
|
Know Labs Inc
AMEX:KNW
|
6.1m USD | -0.7 | -0.4 | |
| JP |
|
Keyence Corp
TSE:6861
|
18.5T JPY | 46.1 | 41.7 | |
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
60.5B USD | 48.7 | 62.9 | |
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
332.6B CNY | 16.2 | 22.3 | |
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
29.7B USD | 51.6 | 31.8 | |
| SE |
|
Hexagon AB
STO:HEXA B
|
266.4B SEK | 27.7 | 12.2 | |
| TW |
|
Chroma ATE Inc
TWSE:2360
|
898B TWD | 370.1 | 76.8 | |
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
192.9B CNY | -1 591.8 | 1 890.2 | |
| UK |
|
Halma PLC
LSE:HLMA
|
17.2B GBP | 48.3 | 49.3 | |
| CN |
|
Huagong Tech Co Ltd
SZSE:000988
|
120.2B CNY | -430.2 | 81.7 | |
| US |
|
Trimble Inc
NASDAQ:TRMB
|
16.1B USD | 55 | 38 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
Know Labs Inc
Glance View
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Seattle, Washington and currently employs 12 full-time employees. The company went IPO on 2006-04-12. The firm offers technology that uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The firm offers a technology called Bio-RFID, which identifies and provides the user with real-time information on their blood glucose levels. Bio-RFID can be integrated into a variety of wearable, mobile or bench-top form factors. Bio-RFID uses radio waves to identify and measure what is going on inside the body. The firm offers UBAND, which is a wearable non-invasive glucose monitor that measures blood glucose levels without fingerpricks or needles. The company helps people with diabetes and pre-diabetes manage their conditions. UBAND’s Bio-RFID sensor detects molecular signatures in other substances such as oxygen, alcohol, and metabolized drugs. Its user can subscribe to multiple monthly services for medical reasons and others lifestyle.
